Molecular Endocrinology, Vol 9, 969-980, Copyright © 1995 by Endocrine Society

ARTICLES

Structural and functional differences in the dio1 gene in mice with inherited type 1 deiodinase deficiency

AL Maia, MJ Berry, R Sabbag, JW Harney and PR Larsen
Thyroid Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

The type 1 deiodinase (D1) provides the major portion of the circulating T3 in vertebrates. In C3H and certain other inbred mice, liver and kidney D1 activity is 5- to 10-fold lower than in the common phenotype, C57. The lower D1 levels are paralleled by a decreased normal-sized dio1 mRNA and hyperthyroxinemia. Low activity cosegregates with a restriction fragment length variant (RFLV) in both inbred and recombinant strains, indicating it is due to differences in the dio1 gene. The exonic structure and the deduced amino acid sequences are identical for both strains and highly homologous to that of the rat. The RFLV is due to an approximately 150-base pair expansion of repetitive sequences in the second intron of the C3H gene, but this segment does not differentially affect the transient expression of a human GH gene. The promoter and 5'-flanking regions of the C3H and C57 dio1 genes are very similar and are GC rich without TATA or CCAAT boxes. However, functional assays of 1.5-kilobase 5'-flanking dio1-CAT constructs showed 2- to 3-fold higher activity of the C57-CAT constructs. Deletion mutants showed that sequences between -705 and - 162 were the cause of this. In this region, the only major difference between the two genes is a 21-base pair insert containing five CTG repeats in the C3H promoter. This difference also cosegregates with low D1 activity and the intron RFLV in four other mouse strains. The correlation of the CTG repeat insert with both in vitro and in vivo expression and the absence of other significant sequence differences in the 5'-flanking region argue that this is the major explanation for the impaired expression of the dio1 gene and the resulting hyperthyroxinemia of the C3H mouse.

This article has been cited by other articles:

				C. Di Cosmo, N. McLellan, X.-H. Liao, K. K. Khanna, R. E. Weiss, L. Papp, and S. Refetoff Clinical and Molecular Characterization of a Novel Selenocysteine Insertion Sequence-Binding Protein 2 (SBP2) Gene Mutation (R128X) J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 4003 - 4009. [Abstract] [Full Text] [PDF]

				R. S. Fortunato, D. L. Ignacio, A. S. Padron, R. Pecanha, M. P. Marassi, D. Rosenthal, J. P. S. Werneck-de-Castro, and D. P Carvalho The effect of acute exercise session on thyroid hormone economy in rats J. Endocrinol., August 1, 2008; 198(2): 347 - 353. [Abstract] [Full Text] [PDF]

				H. Ohguchi, T. Tanaka, A. Uchida, K. Magoori, H. Kudo, I. Kim, K. Daigo, I. Sakakibara, M. Okamura, H. Harigae, et al. Hepatocyte Nuclear Factor 4{alpha} Contributes to Thyroid Hormone Homeostasis by Cooperatively Regulating the Type 1 Iodothyronine Deiodinase Gene with GATA4 and Kruppel-Like Transcription Factor 9 Mol. Cell. Biol., June 15, 2008; 28(12): 3917 - 3931. [Abstract] [Full Text] [PDF]

				M. S Wagner, S. M Wajner, J. M Dora, and A. L. Maia Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient C3H mice J. Endocrinol., June 1, 2007; 193(3): 435 - 444. [Abstract] [Full Text] [PDF]

				M. A. Christoffolete, R. Arrojo e Drigo, F. Gazoni, S. M. Tente, V. Goncalves, B. S. Amorim, P. R. Larsen, A. C. Bianco, and A. M. Zavacki Mice with Impaired Extrathyroidal Thyroxine to 3,5,3'-Triiodothyronine Conversion Maintain Normal Serum 3,5,3'-Triiodothyronine Concentrations Endocrinology, March 1, 2007; 148(3): 954 - 960. [Abstract] [Full Text] [PDF]

				M. J. Schneider, S. N. Fiering, B. Thai, S.-y. Wu, E. St. Germain, A. F. Parlow, D. L. St. Germain, and V. A. Galton Targeted Disruption of the Type 1 Selenodeiodinase Gene (Dio1) Results in Marked Changes in Thyroid Hormone Economy in Mice Endocrinology, January 1, 2006; 147(1): 580 - 589. [Abstract] [Full Text] [PDF]

				P. H. M. Klaren, R. Haasdijk, J. R. Metz, L. M. C. Nitsch, V. M. Darras, S. Van der Geyten, and G. Flik Characterization of an Iodothyronine 5'-Deiodinase in Gilthead Seabream (Sparus auratus) that Is Inhibited by Dithiothreitol Endocrinology, December 1, 2005; 146(12): 5621 - 5630. [Abstract] [Full Text] [PDF]

				A. Coppola, R. Meli, and S. Diano Inverse Shift in Circulating Corticosterone and Leptin Levels Elevates Hypothalamic Deiodinase Type 2 in Fasted Rats Endocrinology, June 1, 2005; 146(6): 2827 - 2833. [Abstract] [Full Text] [PDF]

				K. T. Morgan, Z. Jayyosi, M. A. Hower, M. V. Pino, T. M. Connolly, K. Kotlenga, J. Lin, M. Wang, H.-L. Schmidts, M. S. Bonnefoi, et al. The Hepatic Transcriptome as a Window on Whole-Body Physiology and Pathophysiology Toxicol Pathol, January 1, 2005; 33(1): 136 - 145. [Abstract] [Full Text] [PDF]

				S. Song and T. Oka Regulation of type II deiodinase expression by EGF and glucocorticoid in HC11 mouse mammary epithelium Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1119 - E1124. [Abstract] [Full Text] [PDF]

				S. Friedrichsen, S. Christ, H. Heuer, M. K. H. Schafer, A. Mansouri, K. Bauer, and T. J. Visser Regulation of Iodothyronine Deiodinases in the Pax8-/- Mouse Model of Congenital Hypothyroidism Endocrinology, March 1, 2003; 144(3): 777 - 784. [Abstract] [Full Text] [PDF]

				C. H. J. Verhoelst, K. Vandenborne, T. Severi, O. Bakker, B. Zandieh Doulabi, J. L. Leonard, E. R. Kuhn, S. van der Geyten, and V. M. Darras Specific Detection of Type III Iodothyronine Deiodinase Protein in Chicken Cerebellar Purkinje Cells Endocrinology, July 1, 2002; 143(7): 2700 - 2707. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				J. M. Bates, Vickie. L. Spate, J. S. Morris, D. L. St. Germain, and V. A. Galton Effects of Selenium Deficiency on Tissue Selenium Content, Deiodinase Activity, and Thyroid Hormone Economy in the Rat during Development Endocrinology, July 1, 2000; 141(7): 2490 - 2500. [Abstract] [Full Text] [PDF]

				J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kühn, J. L. Leonard, and T. J. Visser Cloning and Characterization of Type III Iodothyronine Deiodinase from the Fish Oreochromis niloticus Endocrinology, August 1, 1999; 140(8): 3666 - 3673. [Abstract] [Full Text]

				C.-Y. Zhang, S. Kim, J. W. Harney, and P. R. Larsen Further Characterization of Thyroid Hormone Response Elements in the Human Type 1 Iodothyronine Deiodinase Gene Endocrinology, March 1, 1998; 139(3): 1156 - 1163. [Abstract] [Full Text] [PDF]

				S. Van der Geyten, J. P. Sanders, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser Expression of Chicken Hepatic Type I and Type III Iodothyronine Deiodinases during Embryonic Development Endocrinology, December 1, 1997; 138(12): 5144 - 5152. [Abstract] [Full Text] [PDF]

				J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser Characterization of a Propylthiouracil-Insensitive Type I Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5153 - 5160. [Abstract] [Full Text] [PDF]

				B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5452 - 5458. [Abstract] [Full Text] [PDF]

				L. Navarro, A. Landa, C. Valverde-R, and C. Aceves Mammary Gland Type I Iodothyronine Deiodinase Is Encoded by a Short Messenger Ribonucleic Acid Endocrinology, October 1, 1997; 138(10): 4248 - 4254. [Abstract] [Full Text] [PDF]

				N. Toyoda, E. Kaptein, M. J. Berry, J. W. Harney, P. R. Larsen, and T. J. Visser Structure-Activity Relationships for Thyroid Hormone Deiodination by Mammalian Type I Iodothyronine Deiodinases Endocrinology, January 1, 1997; 138(1): 213 - 219. [Abstract] [Full Text] [PDF]